<?xml version="1.0" encoding="UTF-8"?>
<p>The main variants of EIA are as follows: 
 <list list-type="bullet">
  <list-item>
   <p>
    <italic>Fluorescence polarization immunoassay</italic> (
    <italic>FPIA</italic>): uses fluorescent label and polarized light.
   </p>
  </list-item>
  <list-item>
   <p>
    <italic>Micro-particle enzyme immunoassay</italic> (
    <italic>MEIA</italic>) (
    <xref rid="hzw010C75" ref-type="bibr">Tassopoulos 
     <italic>et al</italic>., 1997
    </xref>): widely used and relies on alkaline phosphatase enzyme and a corresponding fluorescent substrate.
   </p>
  </list-item>
  <list-item>
   <p>
    <italic>Chemiluminescent immunoassay</italic> (
    <italic>CLIA</italic>), which uses chemiluminescent or light-emitting labels. Companies like ROCHE or Abbott are exploiting this method, and high-volume laboratories are gradually replacing MEIA technology with CLIA for its high-speed throughput and ease of measurement.
   </p>
  </list-item>
 </list>
</p>
